NOTE AND WARRANT PURCHASE AGREEMENT
THIS NOTE
AND WARRANT PURCHASE AGREEMENT (the "Agreement") is made as of
this 28th day of September, 2005, by and
between Galaxy Nutritional Foods, Inc.,
a Delaware corporation (the "Company"), and
SRB Greenway Capital (Q.P.), L.P.
(the "Investor").
WHEREAS,
the Company desires to issue and sell to selected "accredited
investors" as that term is defined in
Regulation D promulgated under the
Securities Act of 1933, as amended, the
Note and Warrant (as those terms are
defined below).
WHEREAS,
the Investor has agreed to loan to the Company the Loan Amount
(as defined below) (the "Loan") pursuant to
the terms and conditions set forth
herein and in the Note.
WHEREAS,
the Investor acknowledges that the Company is entering into
other
Note and Warrant Purchase Agreements
substantially similar to this Agreement
(the "Other Purchase Agreements") and
offering notes and warrants substantially
similar to the Note and Warrant issued
pursuant to this Agreement (the "Other
Notes" and "Other Warrants", respectively)
to other accredited investors ("Other
Investors") making loans to the Company in
an aggregate amount (including the
Loan) of no more than $2,400,000.
NOW,
THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby
acknowledged, the parties hereto hereby agree as
follows:
ARTICLE I
TERMS OF THE LOAN
Section 1.1 The Loan.
(a) Loan
Amount. Subject to the terms and conditions herein and in the
Note, and subject to the provisions of
Section 1.1(b) hereof, the Investor
agrees to loan to the Company $485,200.00
(the "Loan Amount"), which Loan shall
evidenced by a Promissory Note in favor of
the Investor, in the form attached
hereto as Exhibit A (the "Note"), dated the
date on which such funds were
received by the Company from the Investor.
The Loan shall be made in accordance
with and subject to the terms and
conditions of the Note.
(b)
Payment of the Loan Amount. The Loan Amount from the Investor shall
be
paid to the Company upon or prior to
October 3, 2005.
Section 1.2 Use of Proceeds. The proceeds
of the Loan shall be used by the
Company primarily for general working
capital and other general corporate
purposes for the Company and its
affiliates, and as otherwise provided herein.
Section 1.3 Conditions Precedent. The
Investor's obligation to make the Loan
shall be subject to the fulfillment to the
Investor's satisfaction of the
following conditions:
(a)
Delivery of Note and Warrant. The Investor shall have received a
fully
executed Note and a fully executed
redeemable warrant certificate to purchase
such number of shares of common stock of
the Company equal to 1 share per every
$4 of the Loan Amount in the form attached
hereto as Exhibit B (the "Warrant").
<PAGE>
(b)
Delivery of Registration Rights Agreement. The Investor shall
have
received a fully executed Registration
Rights Agreement in the form attached
hereto as Exhibit C (the "Registration
Rights Agreement").
(c)
Representations and Covenants. All of the representations and
warranties of the Company herein shall be
true and correct and it shall have
fulfilled all of its obligations hereunder
in all material respects.
(d)
Absence of Violation or Litigation. The consummation of the
transactions contemplated hereby shall not
be in violation of any law or
regulation applicable to the Company. The
Company shall not be subject to any
injunction, stay or restraining order nor
shall it be required to make or to
obtain any filings, approvals or consents
which shall not have been previously
made or obtained.
(e) All
Proceedings Satisfactory. All organizational and other
proceedings
taken by the Company in connection with the
transactions contemplated by this
Agreement, and all documents and
instruments related thereto, shall be
reasonably satisfactory in form and
substance to the Investor, and the Investor
shall have received copies thereof and
other materials (certified, if requested)
as it may reasonably request in connection
therewith. The issuance and sale of
the Note and the Warrant shall be made in
conformity with all applicable state
and federal securities laws.
ARTICLE II
REPRESENTATIONS AND WARRANTIES; COVENANTS.
Section 2.1 Company Representations and
Warranties.
(a) Organization and Company Power. The Company is a
corporation
duly organized, validly existing and in
good standing under the laws of the
State of Delaware. The Company has all
required power and authority to carry on
its business as presently conducted, to
enter into and perform this Agreement,
the Note, the Warrant, the Registration
Rights Agreement and any other
agreements contemplated hereby to which it
is a party and to carry out the
transactions contemplated hereby and
thereby.
(b) Authorization and Non-Contravention. This Agreement and all
documents executed pursuant hereto are
valid and binding obligations of the
Company, enforceable in accordance with
their terms. The execution, delivery and
performance of this Agreement and all
agreements, documents and instruments
contemplated hereby, the issuance and
delivery of the Note and Warrant and, upon
exercise of the Warrant, the issuance and
delivery of the equity securities
purchasable upon exercise of the Warrant,
have been duly authorized by all
necessary corporate or other action of the
Company.
2
<PAGE>
Section 2.2 Securities Law Compliance.
(a) The
Investor agrees that its Note, Warrant, and the securities
issuable upon exercise of the Warrant, are
being acquired for investment and
that such Investor will not offer, sell or
otherwise dispose of its Note,
Warrant, or any securities issuable upon
exercise of the Warrant, except under
circumstances which will not result in a
violation of the Securities Act of
1933, as amended (the "Securities Act"), or
any applicable state securities
laws. Each Note, Warrant and all securities
issued upon exercise of the Warrant
(unless registered under the Securities Act
and any applicable state securities
laws) shall be stamped or imprinted with a
legend in substantially the following
form:
"THESE SECURITIES HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), OR ANY
APPLICABLE STATE SECURITIES LAW AND MAY
NOT BE SOLD, OFFERED FOR SALE, MORTGAGED,
PLEDGED, HYPOTHECATED OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO (A) AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS, OR (B) AN EXEMPTION
THEREFROM, AND, IF REQUESTED BY THE
COMPANY, THE COMPANY HAS RECEIVED AN OPINION
OF COUNSEL SATISFACTORY TO THE COMPANY THAT
THE TRANSFER IS EXEMPT FROM THE
REGISTRATION PROVISIONS OF THE SECURITIES
ACT AND APPLICABLE STATE SECURITIES
LAWS."
(b)
Restricted Securities. The Investor understands that its Note,
Warrant
and the securities issuable upon exercise
of the Warrant, will not be registered
at the time of their issuance under the
Securities Act for the reason that the
sales provided for in this Agreement are
exempt pursuant to Section 4(2) of the
Securities Act based on the representations
of the Investor set forth herein.
The Investor represents that it is
experienced in evaluating companies such as
the Company, has such knowledge and
experience in financial and business matters
as to be capable of evaluating the merits
and risks of its investment, and has
the ability to suffer the total loss of the
investment. The Investor further
represents that it has had the opportunity
to ask questions of and receive
answers from the Company concerning the
terms and conditions of its Note,
Warrant and the business of the Company,
and to obtain additional information to
such Investor's satisfaction. All
documents, records and books pertaining to the
Company and this investment have been made
available to the Investor and its
representatives, including each Investor's
attorney and accountant, that the
books and records of the Company will be
available upon reasonable notice for
inspection by the Investor during
reasonable business hours at the Company's
principal place of business, and the
Investor have had access to and the
opportunity to request information from and
ask questions of the officers and a
directors of the Company. The Investor
further represents that it is an
"accredited investor" within the meaning of
Regulation D under the Securities
Act, as presently in effect. The Investor
further represents that the Note and
the Warrant are being acquired for the
account of such Investor for investment
only and not with a view to, or with any
intention of, a distribution or resale
thereof, in whole or in part, or the grant
of any participation therein. If an
Investor is a corporation, business trust,
partnership, limited liability
company or other entity, such Investor
represents that it was not formed for the
specific purpose of acquiring the
securities offered hereby and has total assets
3
<PAGE>
of more than $5,000,000. If an Investor is
an individual, such Investor
represents that (A) the Investor is a
natural person whose individual net worth,
or joint net worth with spouse, exceeds $1
million at the time of purchase (in
this instance, the term "net worth" means
the excess of assets at fair market
value, including home and personal
property, over total liabilities, including
mortgages and income taxes on unrealized
appreciation of assets); or (B) the
Investor is a natural person who has had
individual income of more than $200,000
in each of the two most recent years (2003
and 2004), or joint income with that
person's spouse of more than $300,000 in
each of those years, and reasonably
expects to reach the same income level in
the current year (2005). (The term
"individual income" means adjusted gross
income as reported for federal income
tax purposes, less any income attributable
to a spouse or to property owned by a
spouse, increased by the following amounts
(excluding any amount attributable to
a spouse or to property owned by a spouse):
(1) the amount of any interest
income received which is tax-exempt under
Section 103 of the Internal Revenue
Code of 1986, as amended (the "Code"); (2)
the amount of losses claimed as a
partner in a limited partnership (as
reported on Schedule E of Form 1040); and
(3) any deduction claimed for depletion
under Section 611 et seq. of the Code).
(c) State
of Residence. The Investor represents that it is a legal
resident of, or, if such Investor is an
entity, has its principal place of
business in, the state listed on the
signature page of this Agreement.
Section 2.3 Advice of Consultants. The
Investor has obtained the advice of
independent counsel and tax advisors of
Investor's choice in entering into this
Agreement and the transactions contemplated
hereby or has knowingly elected not
to receive such counsel.
Section 2.4 No Preferential Treatment.
Until all of the Company's obligations
hereunder are paid and performed in full,
the Company shall not, without the
prior consent of the Investor, (a) make any
payment or other consideration with
respect to any Other Note unless the
Company makes the same payment or other
consideration with respect to the Note, pro
rata based on the relative principal
amounts of the Note and Other Notes; or (b)
amend or waive any provision of any
Other Purchase Agreement, Other Note or
Other Warrant that would (i) increase
the interest rate of such Other Note, (ii)
shorten the maturity date of such
Other Note, (iii) provide for any payments
of principal prior to maturity under
such Other Note, or (iv) otherwise
materially adversely affect the rights of the
Investor hereunder or under the Note or
Warrant.
Section 2.5 Indebtedness Covenant.
(a) Until
all of the Company's obligations hereunder are paid and
performed in full, the Company shall not,
without the prior consent of the
Investor, incur any Indebtedness other than
(i) the obligations incurred hereby
or pursuant to the Other Purchase
Agreements not exceeding $2,400,000 in
principal in the aggregate outstanding at
any time, (ii) obligations to Textron
Financial Corporation, or its successors or
assigns, not exceeding $7,500,000 in
principal in the aggregate outstanding at
any time, (iii) obligations to
Wachovia Bank, N.A., or its successors or
assigns, not exceeding $11,000,000 in
principal in the aggregate outstanding at
any time, and (iv) any other
indebtedness not otherwise permitted by
this Section 2.5 not exceeding
$5,000,000 in principal in the aggregate
outstanding at any time.
(b) As
used herein, "Indebtedness" means any liability or obligation
(i)
for borrowed money, other than trade
payables incurred in the ordinary course of
business, (ii) evidenced by bonds,
debentures, notes, or other similar
instruments, (iii) in respect of letters of
credit or other similar instruments
(or reimbursement obligations with respect
thereto), except letters of credit or
other similar instruments issued to secure
payment of trade payables arising in
4
<PAGE>
the ordinary course of business, (iv) to
pay the deferred purchase price of
property or services, except trade payables
arising in the ordinary course of
business, (v) as lessee under capitalized
leases, (vi) secured by a Lien on any
asset of the Company, whether or not such
obligation is assumed by the Company;
provided, however, Indebtedness shall not
be deemed to include (x) any liability
or obligation as lessee under any operating
leases, (y) any letters of credit or
similar instruments issued to secured
payment of rent under any operating
leases, or (z) any payroll obligations. As
used herein "Lien" means any lien,
mortgage, deed of trust, pledge, security
interest, charge or encumbrance of any
kind (including any conditional sale or
other title retention agreement, any
lease in the nature thereof and any
agreement to give any of the foregoing).
ARTICLE III
TRANSFER RESTRICTIONS
Section 3.1 Transfers Void. The Investor
agrees that it may not sell, give,
transfer, assign or otherwise dispose of
its Note or Warrant, except as
expressly permitted by Section 3.2 hereof.
Any purported sale, gift, transfer,
assignment or other disposition, or pledge
of or grant of security interest in,
any Note or Warrant in violation of this
Article III shall be null and void.
Section 3.2 Transfers to Affiliates. The
Investor may, at any time, transfer all
of such Investor's Note and Warrant (but
not less than all, and not separately),
to any of its affiliates, provided such
affiliate is an "accredited investor."
Section 3.3 Legend. The Note and the
Warrant shall be stamped or imprinted with
a legend in substantially the following
form:
"THIS NOTE/WARRANT IS SUBJECT TO THE
PROVISIONS OF A NOTE AND WARRANT AGREEMENT,
INCLUDING THEREIN CERTAIN RESTRICTIONS ON
TRANSFER. A COMPLETE AND CORRECT COPY
OF SUCH AGREEMENT IS AVAILABLE FOR
INSPECTION AT THE PRINCIPAL OFFICE OF THE
COMPANY AND WILL BE FURNISHED UPON WRITTEN
REQUEST AND WITHOUT CHARGE."
ARTICLE IV
DEFAULT
Section 4.1 Events of Default. With respect
to the Investor, if, while any part
of the principal of the Investor's Note
remains unpaid, any one of the following
"Events of Default" shall occur:
(a) An
order, judgment or decree shall be entered by any court of
competent jurisdiction, approving a
petition seeking reorganization or
liquidation of the Company, or appointing a
receiver, trustee or liquidator of
the Company of all or a substantial part of
its assets, which such order,
judgment or decree has not been effectively
stayed within sixty (60) days after
entry;
(b) the
Company shall (i) from this date forward, admit in writing to
its
inability to pay its debts as they mature;
(ii) make a general assignment for
the benefit of creditors; (iii) be
adjudicated bankrupt or insolvent; (iv) file
5
<PAGE>
a voluntary petition in bankruptcy or a
petition or an answer seeking
reorganization or an arrangement with
creditors to take advantage of any
insolvency law; (v) file any answer
admitting the material allegations of a
petition filed against it in any
bankruptcy, reorganization or insolvency
proceeding or fail to dismiss such petition
within sixty (60) days after the
filing thereof; or (vi) take any action for
the purpose of effecting any of the
foregoing;
(c) the
failure by the Company to observe and perform any material
covenant, condition and agreement under
this Agreement which failure is not
cured within thirty (30) days, after
written notice from the Investor or
discovery by the Company; and
(d) the
failure by the Company to observe and perform any material
covenant, condition and agreement under the
Note or Warrant which failure is not
cured within the applicable cure period (or
thirty (30) days if no cure period
is expressly provided for such failure),
after written notice from the Investor
or discovery by the Company;
then and in every such event such Investor
may, upon written notice to the
Company, declare the Note to be due and
payable in full, whereupon the Note
shall become due and payable in full.
ARTICLE V
MISCELLANEOUS
Section 5.1 Notices. All necessary notices,
demands and requests permitted or
required under this Agreement shall be in
writing and shall be deemed effective
(a) if given by facsimile, when such
facsimile is transmitted to the facsimile
number specified below, the appropriate
answer back is received and a copy is
sent to such party by an express mail
carrier at the address indicated below,
(b) three business days after being mailed
by certified mail, return receipt
requested, postage prepaid to the
applicable party at the address indicated
below or (c) one business day after being
sent by an express mail carrier to the
applicable party at the address indicated
below:
If to the Company: Galaxy
Nutritional Foods, Inc.
2441 Viscount Row
Orlando, Florida 32809
Facsimile: (407) 855-1099
Attention: Michael E. Broll
With copies to:
Baker & Hostetler LLP
200 S. Orange Avenue, Suite 2300
Orlando, Florida
32801
Facsimile: (407) 841-0168
Attn: Kenneth C. Wright, Esq.
If to the Investor: 300 Crescent
Court
Suite 1111
Dallas, Texas 75201
Facsimile: ___________________
Attention: ___________________
6
<PAGE>
or such other address or facsimile number
as such party may hereafter specify
for the purpose of receiving notice
hereunder. A copy of any notice to the
Investor shall be provided, as described
above, to any counsel designated by the
Investor in writing to the Company as above
provided.
Section 5.2 No Waiver. No failure to
exercise, and no delay in exercising, on
the part of an Investor, any right, power
or privilege hereunder shall operate
as a waiver thereof; nor shall any single
or partial exercise of any right,
power or privilege hereunder preclude any
other or further exercise thereof or
the exercise of any other right, power or
privilege. The rights and remedies
herein provided are cumulative and not
exclusive of any rights or remedies
provided by law.
Section 5.3 Governing Law; Construction.
This Agreement, the Note, the Warrant
and the Registration Rights Agreement shall
each be deemed to be a contract made
under the laws of the State of Florida, and
shall be construed in accordance
with the laws of the State of Florida. The
descriptive headings of the several
Sections hereof are for convenience only
and shall not control or affect the
meaning or construction of any of the
provisions hereof. This Agreement, the
Note, the Warrant and the Registration
Rights Agreement together with the
Exhibits hereto and thereto and all
documents, instruments and agreements
executed pursuant hereto, constitute the
entire agreement and understanding
between the parties hereto with respect to
the subject matter hereof, supersede
all prior agreements, understandings or
representations pertaining to the
subject matter hereof, whether oral or
written, and may not be contradicted by
evidence of any alleged oral agreement.
Venue for any action brought under this
Agreement, the Note, the Warrant or the
Registration Rights Agreement shall be
in Orange County, Florida.
Section 5.4 Amendments, Waivers and
Consents. Any term, covenant or condition of
this Agreement may be amended, omitted or
waived (either generally or in a
particular instance and either
retroactively or prospectively) only by written
consent of all of the parties hereto.
Section 5.5 Expenses. Any expense incurred
by either party (including, without
limitation, reasonable attorneys' fees and
disbursements) in connection with the
negotiation, execution, administration or
enforcement of this Agreement, the
Note, the Warrant, the Registration Rights
Agreement and any other document
executed in connection with the obligations
hereunder or thereunder and any
amendment hereto or thereto shall be the
sole responsibility and shall be paid
such party.
Section 5.6 Counterparts. This Agreement
may be executed in two or more
counterparts, each of which shall be deemed
an original and all of which
together shall constitute but one and the
same instrument. The signatures to
this Agreement need not all be on a single
copy of this Agreement, and may be
facsimiles rather than originals, and shall
be fully as effective as though all
signatures were originals on the same
copy.
Section 5.7 Attorneys' Fees. In the event
of a judicial or administrative
proceeding or action by one party against
the other party with respect to the
interpretation or enforcement of this
Agreement, the prevailing party shall be
entitled to recover reasonable costs and
expenses including reasonable
attorneys' fees and expenses, whether at
the investigative, pretrial, trial or
appellate level. The prevailing party shall
be determined by the court based
upon an assessment of which party's major
arguments or position prevailed.
Section 5.8 Construction of Agreement. This
Agreement shall not be construed
more strictly against one party than
against the other merely by virtue of the
fact that it may have been prepared
primarily by counsel for one of the parties.
* * *
7
<PAGE>
IN WITNESS
WHEREOF, the parties hereto have executed this Agreement under
seal as of the date first above
written.
"COMPANY"
GALAXY NUTRITIONAL FOODS, INC., a
Delaware corporation
By: /s/ Michael
E. Broll
---------------------------------------
Michael E. Broll
Chief Executive Officer
"INVESTOR"
SRB GREENWAY CAPITAL (Q.P.), L.P.
-----------------------------------------
(Name of Entity)
By: /s/ Steven R.
Becker
-------------------------------------
(Signature of Individual Executing)
Member
-----------------------------------------
(Title)
Steven R. Becker
-----------------------------------------
(Print Name)
-----------------------------------------
(FEIN)
$485,200.00
-----------------------------------------
(Amount of Advance)
Texas
-----------------------------------------
State of Residency or Principal Place of
Business
8
<PAGE>
EXHIBIT A
THIS SECURITY HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS
AMENDED (THE "ACT"), OR ANY APPLICABLE
STATE LAW, AND MAY NOT BE SOLD,
DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR
OTHERWISE TRANSFERRED UNLESS (A)
THERE IS AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS COVERING ANY SUCH
TRANSACTION OR (B) SUCH TRANSACTION IS EXEMPT
FROM REGISTRATION AND, IF REQUESTED BY THE
MAKER, THE MAKER HAS RECEIVED AN
OPINION OF COUNSEL SATISFACTORY TO THE
MAKER THAT THE TRANSFER IS EXEMPT FROM
THE REGISTRATION PROVISIONS UNDER THE ACT
AND ANY APPLICABLE STATE SECURITIES
LAWS.
THIS NOTE IS SUBJECT TO THE PROVISIONS OF A
NOTE AND WARRANT AGREEMENT,
INCLUDING THEREIN CERTAIN RESTRICTIONS ON
TRANSFER. A COMPLETE AND CORRECT COPY
OF SUCH AGREEMENT IS AVAILABLE FOR
INSPECTION AT THE PRINCIPAL OFFICE OF THE
COMPANY AND WILL BE FURNISHED UPON WRITTEN
REQUEST AND WITHOUT CHARGE
PROMISSORY NOTE
$______________
__________ __, 2005
FOR VALUE
RECEIVED, the undersigned, GALAXY NUTRITIONAL FOODS, INC., a
Delaware corporation ("Maker"), promises to
pay to the order of _______________
("Payee"; Payee and any subsequent
holder[s] hereof are hereinafter referred to
collectively as "Holder"), at the office of
Payee at
__________________________________, or at
such other place as Holder may
designate to Maker in writing from time to
time, the principal sum of
______________________________ AND
NO/100THS DOLLARS ($_________.00), together
with interest on the outstanding principal
balance hereof from the date hereof
at the Interest Rate, in lawful money of
the United States. Amounts payable
hereunder shall be paid, at Payee's option
as specified by Payee in writing from
time to time, either by (i) check delivered
to the office of Payee or (ii) wire
transfer of immediately available funds to
an account specified by Payee in
writing from time to time. This Note is
referred to in and issued pursuant to
that certain Note and Warrant Purchase
Agreement, dated as of September 28,
2005, by and between Payee and Maker (as
amended from time to time, the
"Agreement").
The
Interest Rate shall be a floating rate calculated at an annual
rate
equal to three percent (3.0%) per annum in
excess of the Bank Prime Rate of
Interest per the Federal Reserve Bank in
effect from time to time, calculated on
the basis of a 360-day year, actual days
elapsed, upon the principal balance
hereof from time to time outstanding, but
in no event to exceed the Maximum Rate
(as defined below). Each adjustment in the
Interest Rate shall be effective on
the day the change in the Bank Prime Rate
occurs.
Interest
only on the outstanding principal balance hereof shall be due
and
payable monthly, in arrears, with the first
installment being payable on the
fifteenth (15th) day of October, 2005, and
subsequent installments being payable
on the fifteenth (15th) day of each
succeeding month thereafter until June 15,
2006 (the "Maturity Date"), at which time
the entire outstanding principal
<PAGE>
balance, together with all accrued and
unpaid interest, shall be immediately due
and payable in full. If any such day is not
a business day, such payment shall
be made on the next succeeding day which is
a business day and interest shall
continue to accrue thereon until paid. As
used herein, "business day" means a
day, other than a Saturday, Sunday or legal
holiday, on which commercial banks
in Orlando, Florida are open for the
general transaction of business.
The
indebtedness evidenced hereby may be prepaid in whole or in part,
at
any time and from time to time, without
premium or penalty. Any such prepayments
shall be credited first to any accrued and
unpaid interest and then to the
outstanding principal balance hereof.
The
failure of Maker to pay any principal, interest or any other
sums
required hereunder when due under this Note
shall constitute a default. If (i) a
default shall occur hereunder and such
default shall continue for ten (10) days
after notice thereof is delivered by Holder
to Maker, or (ii) an Event of
Default shall occur under the Agreement,
which Event of Default is not cured
following the giving of any applicable
notice and within any applicable cure
period set forth in the Agreement, then,
and in such event, the entire
outstanding principal balance of the
indebtedness evidenced hereby, together
with any other sums advanced hereunder
and/or under any other instrument or
document now or hereafter evidencing,
securing or in any way relating to the
indebtedness evidenced hereby, together
with all unpaid interest accrued
thereon, shall, at the option of Holder and
without notice to Maker, at once
become due and payable and may be collected
forthwith, regardless of the
stipulated date of maturity. Upon the
occurrence of a default as set forth
herein or in the Agreement, which default
is not cured following the giving of
any applicable notice and within any
applicable cure period set forth herein, at
the option of Holder and without notice to
Maker, all accrued and unpaid
interest, if any, shall be added to the
outstanding principal balance hereof,
and the entire outstanding principal
balance, as so adjusted, shall bear
interest thereafter until paid at an annual
rate (the "Default Rate") equal to
the lesser of (i) the rate that is five
percentage points (5.0%) in excess of
the above-specified Interest Rate on the
date of such default, or (ii) the
maximum rate of interest allowed to be
charged under applicable law (the
"Maximum Rate"), regardless of whether or
not there has been an acceleration of
the payment of principal as set forth
herein.
In the
event this Note is placed in the hands of an attorney for
collection, or if Holder incurs any costs
incident to the collection of the
indebtedness evidenced hereby, Maker and
any endorsers hereof agree to pay to
Holder an amount equal to all such costs,
including, without limitation, all
reasonable attorneys' fees and all court
costs.
Presentment for payment, demand, protest and notice of demand,
protest and
nonpayment are hereby waived by Maker and
all other parties hereto. No failure
to accelerate the indebtedness evidenced
hereby by reason of a default
hereunder, acceptance of a past-due
installment or other indulgences granted
from time to time, shall be construed as a
novation of this Note or as a waiver
of such right of acceleration or of the
right of Holder thereafter to insist
upon strict compliance with the terms of
this Note or to prevent the exercise of
such right of acceleration or any other
right granted hereunder or by applicable
law. No extension of the time for payment
of the indebtedness evidenced hereby
2
<PAGE>
or any installment due hereunder, made by
agreement with any person now or
hereafter liable for payment of the
indebtedness evidenced hereby, shall operate
to release, discharge, modify, change or
affect the original liability of Maker
hereunder or that of any other person now
or hereafter liable for payment of the
indebtedness evidenced hereby, either in
whole or in part, unless Holder agrees
otherwise in writing. This Note may not be
changed orally, but only by an
agreement in writing signed by the party
against whom enforcement of any waiver,
change, modification or discharge is
sought.
All
agreements herein made are expressly limited so that in no
event
whatsoever, whether by reason of
advancement of proceeds hereof, acceleration of
maturity of the unpaid balance hereof or
otherwise, shall the amount paid or
agreed to be paid to Holder for the use of
the money advanced or to be advanced
hereunder exceed the Maximum Rate. If, from
any circumstances whatsoever, the
fulfillment of any provision of this Note
or any other agreement or instrument
now or hereafter evidencing, securing or in
any way relating to the indebtedness
evidenced hereby shall involve the payment
of interest in excess of the Maximum
Rate, then, ipso facto, the obligation to
pay interest hereunder shall be
reduced to the Maximum Rate; and if from
any circumstance whatsoever, Holder
shall ever receive interest, the amount of
which would exceed the amount
collectible at the Maximum Rate, such
amount as would be excessive interest
shall be applied to the reduction of the
principal balance remaining unpaid
hereunder and not to the payment of
interest. This provision shall control every
other provision in any and all other
agreements and instruments existing or
hereafter arising between Maker and Holder
with respect to the indebtedness
evidenced hereby.
This Note
is intended as a contract under and shall be construed and
enforceable in accordance with the laws of
the State of Florida, and shall be
enforceable in a court of competent
jurisdiction in the State of Florida,
regardless of in which state this Note is
being executed.
HOLDER AND
MAKER HEREBY KNOWINGLY AND VOLUNTARILY WITH THE BENEFIT OF
COUNSEL WAIVE TRIAL BY JURY IN ANY ACTIONS,
PROCEEDINGS, CLAIMS OR
COUNTER-CLAIMS, WHETHER IN CONTRACT OR TORT
OR OTHERWISE, AT LAW OR IN EQUITY,
ARISING OUT OF OR IN ANY WAY RELATING TO
THIS NOTE.
As used
herein, the terms "Maker" and "Holder" shall be deemed to
include
their respective successors, legal
representatives and assigns, whether by
voluntary action of the parties or by
operation of law.
MAKER:
GALAXY NUTRITIONAL FOODS, INC.
a Delaware corporation
By:
---------------------------------------
Michael E. Broll
Chief Executive Officer
3
<PAGE>
EXHIBIT B
THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE
NOT
BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY
NOT BE
SOLD,
OFFERED FOR SALE, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO (A) AN EFFECTIVE REGISTRATION
STATEMENT
UNDER THE
SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (B)
AN
EXEMPTION THEREFROM AND, IF REQUESTED BY THE COMPANY, THE COMPANY
HAS
R